Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...

Eli Lilly is a leader in the market for GLP-1 medicines. The company's Zepbound, indicated for weight loss, is racking up ...

Only one of these growth stocks is up big so far in 2025. But all three could be huge winners over the next few years.

COMMENT: The astronomical rise in weight-loss drug prices caused by Trump’s tariffs could have a significant – and dangerous ...

Eli Lilly and Company (NYSE:LLY)’s pipeline has been advancing, thanks to positive study results in oncology and ...

Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy according to analysts. On August 14, Eli Lilly and ...

DEAR ERIC: I’ve been taking yoga classes for at least eight years from a woman who teaches a small group in her yard. I’m ...

Going up against these giants is no small challenge, but Viking is, so far, holding its own. And if it can play its cards ...

A yoga enthusiast quit her class of eight years because the teacher repeatedly mocked her. But is it OK for her to return ...

Dear Eric: I’ve been taking yoga classes for at least eight years from a woman who teaches a small group in her yard. I’m ...

Alexa Bliss currently holds the WWE Women's Tag Team Championship alongside Charlotte Flair. The Queen and The Goddess made their presence felt on SmackDown this week.

Novo Nordisk (NYSE: NVO) first earned U.S. approval for its now-famous weight management medicine Wegovy in June 2021. That marked the beginning of a strong run for the company on the stock market.